Javascript must be enabled to continue!
TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
View through CrossRef
Previous large-scale genetic studies identified single nucleotide polymorphisms (SNPs) of the TM6SF2 and MBOAT7 genes as risk factors for alcoholic liver cirrhosis and non-alcoholic fatty liver disease. In this study, we tried to evaluate the association between TM6SF2 variant rs58542926 and MBOAT7 variant rs641738 and the risk of hepatic fibrosis or liver cirrhosis of different etiology. In parallel, we also aimed to evaluate whether these two SNPs modify the effects of the PNPLA3 rs738409 risk variant for the development of hepatic fibrosis and liver cirrhosis. The study was conducted at the Department of Gastroenterology, Lithuanian University of Health Sciences Hospital, and included 334 patients with liver cirrhosis, 128 patients with liver fibrosis, and 550 controls. SNPs were genotyped by quantitative PCR, using TaqMan allelic discrimination assays. Overall, TM6SF2 rs58542926 as well as MBOAT7 rs641738 were not linked to hepatic fibrosis, alcohol or hepatitis C virus induced liver cirrhosis in an Eastern European population. These genetic variations also did not mediate the effect of PNPLA3 rs738409 SNP for liver developing liver fibrosis or liver cirrhosis.
Title: TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
Description:
Previous large-scale genetic studies identified single nucleotide polymorphisms (SNPs) of the TM6SF2 and MBOAT7 genes as risk factors for alcoholic liver cirrhosis and non-alcoholic fatty liver disease.
In this study, we tried to evaluate the association between TM6SF2 variant rs58542926 and MBOAT7 variant rs641738 and the risk of hepatic fibrosis or liver cirrhosis of different etiology.
In parallel, we also aimed to evaluate whether these two SNPs modify the effects of the PNPLA3 rs738409 risk variant for the development of hepatic fibrosis and liver cirrhosis.
The study was conducted at the Department of Gastroenterology, Lithuanian University of Health Sciences Hospital, and included 334 patients with liver cirrhosis, 128 patients with liver fibrosis, and 550 controls.
SNPs were genotyped by quantitative PCR, using TaqMan allelic discrimination assays.
Overall, TM6SF2 rs58542926 as well as MBOAT7 rs641738 were not linked to hepatic fibrosis, alcohol or hepatitis C virus induced liver cirrhosis in an Eastern European population.
These genetic variations also did not mediate the effect of PNPLA3 rs738409 SNP for liver developing liver fibrosis or liver cirrhosis.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Introduction. Chronic diffuse liver lesions, which is at a certain stage and phase of the disease characterized by excessive accumulation of components of the extracellular matrix,...
RADIOLOGICAL SPECTRUM OF FATTY LIVER CORRELATES WITH HIGH-RESOLUTION ULTRASONOGRAPHY OF FIBROSIS AND CIRRHOSIS
RADIOLOGICAL SPECTRUM OF FATTY LIVER CORRELATES WITH HIGH-RESOLUTION ULTRASONOGRAPHY OF FIBROSIS AND CIRRHOSIS
Background: Fatty liver disease, fibrosis, and cirrhosis represent a spectrum of liver conditions that pose significant health risks globally. Accurate diagnosis and staging of the...
The Differential Gene Expression Analysis Of Hepatic Inflammatory Genes For Diagnosis Of Early Stages Of Fibrosis In Non Alcoholic Fatty Liver Disease (NAFLD)
The Differential Gene Expression Analysis Of Hepatic Inflammatory Genes For Diagnosis Of Early Stages Of Fibrosis In Non Alcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic Fatty Liver Disease (NAFLD) is the common liver metabolic disorders, which affects more than 30% of the world’s population. If NAFLD is left untreated, it progresses t...
Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia
Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia
Objectives:Gene variants are important factors in prognosis of the patients with hematological malignancies. In current study, our team investigate the relationship between blood a...
High expression of FAM13A was associated with increasing the liver cirrhosis risk
High expression of FAM13A was associated with increasing the liver cirrhosis risk
AbstractAimLiver cirrhosis is a consequence of chronic liver disease, and it may be caused by multiple influences of both genetic and environmental factors. Family with sequence si...
A systematic review on contemporary serum biomarkers for predicting liver fibrosis
A systematic review on contemporary serum biomarkers for predicting liver fibrosis
Excessive extracellular matrix (ECM) deposition in the liver is a hallmark of liver fibrosis, a basic pathological process in the majority of chronic liver disorders (CLD). It is b...

